Somnics, Inc.

Somnics, Inc. develops innovative medical devices for the treatment of Obstructive Sleep Apnea (OSA). The company's flagship product is the iNAP® Sleep Therapy System, a portable intraoral negative pressure therapy device that provides an alternative to traditional CPAP machines and surgical interventions. The iNAP system operates without facial masks, belts, or large hoses, utilizing a soft, flexible oral interface with thermal-memory material in a one-size-fits-all design. The device is battery-powered, ultra-compact, and travel-friendly, designed for patient comfort and discretion during sleep. Key features include natural nasal breathing without forced air delivery, quiet operation, portability with rechargeable battery capability, and superior wearing comfort. The iNAP One Sleep Therapy System is listed on the U.S. Federal Supply Schedule and is currently deployed across over 36 VA Medical Centers within the Veterans Affairs healthcare system. Clinical evidence supporting the iNAP system has been published in peer-reviewed journals including Sleep and Breathing, demonstrating significant improvements in treatment success rates and sleep quality for OSA patients. The company holds an extensive patent portfolio spanning the United States, Europe, Japan, Korea, Australia, and other international jurisdictions, covering the iNAP sleep therapy system and related methodologies. Somnics serves both individual patients and institutional healthcare markets, including the federal VA healthcare system.